Improving the quality of human research protection programs is a top priority for AAHRPP. Effective and efficient systems of oversight within organizations provide better protections for research participants and produce higher quality research. And collectively, they raise the bar globally to ensure research participants are safe and respected.
From data supplied by client organizations in 2010, AAHRPP has compiled an information database to help research organizations, researchers, sponsors, government agencies, and participants identify and support high-performing practices for human research protection programs (HRPPs).
Published here are the 2010 metrics for HRPP performance. The data range from types of research and conformance with regulations and guidance to financial and personnel resources and IRB review times.
A PDF version of the 2010 metrics will be available shortly. The 2009 metrics are available on the Website here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
SCOPE Summit 2025 Opening Keynote Panel: What Do Real Patients Actually Talk About?
February 3rd 2025Interactive panel on day 1 of SCOPE Summit 2025 highlighted the need for inclusive narratives, social listening to understand patient experiences, and the role of advocacy groups in opening doors to clinical trials.